Birchview Capital, LP Atara Biotherapeutics, Inc. Transaction History

Birchview Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$12.03 - $19.94 $240,600 - $398,800	-20,000 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$19.05 - $41.04 $76,200 - $164,160	-4,000 Reduced 16.67%	20,000 $402,000
Q1 2019 May 03, 2019	SELL	$28.4 - $41.74 $284,000 - $417,400	-10,000 Reduced 29.41%	24,000 $954,000
Q2 2018 Aug 02, 2018	BUY	$35.15 - $51.45 $386,650 - $565,950	11,000 Added 47.83%	34,000 $1.25 Million
Q1 2018 May 07, 2018	BUY	$18.0 - $48.35 $414,000 - $1.11 Million	23,000 New	23,000 $897,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.51B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.